Article Text

Download PDFPDF
Three-vessel coronary artery aneurysmal disease complicated by multivessel thrombosis and cardiogenic shock: the saving role of intracoronary thrombolysis
  1. Luis Pablo Roldan1,
  2. Chris Rowan2,
  3. Mark Sheldon3,
  4. Carlos A Roldan1
  1. 1Department of Cardiology, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA
  2. 2University of Nevada, Reno School of Medicine, Reno, Nevada, USA
  3. 3Department of Cardiology, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA
  1. Correspondence to Luis Pablo Roldan, lroldan{at}


The benefit of intracoronary thrombolytics in ST-elevation myocardial infarction (STEMI) is not well established. Mainstays of STEMI management include intravenous thrombolytics, percutaneous coronary interventions and surgical revascularisation. However, in cases of STEMI secondary to coronary artery aneurysmal disease (CAAD), standard treatment options may not be suitable due to high thrombus burden, perioperative risk and factors unique to each patient. Thus, STEMI management in CAAD can represent a therapeutically challenging clinical scenario. Here, we describe a patient with severe three-vessel CAAD complicated by multivessel thrombosis and cardiogenic shock for whom traditional management options including placement of haemodynamic support devices were not feasible. As an alternative measure, the patient was treated with intracoronary thrombolysis with remarkable clinical stabilisation and angiographic resolution of thrombosis. He remains clinically stable several years later without recurrent events. This case serves to demonstrate the potential lifesaving benefit of intracoronary thrombolysis in complicated multivessel CAAD.

  • heart failure
  • ischaemic heart disease
  • contraindications and precautions
  • cardiovascular system
  • interventional cardiology

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors LPR wrote and formatted the manuscript and conducted the literature review. The other authors listed, CR, MS and CAR, participated in the management of the patient, edited and reviewed the manuscript, and approved the case before submission.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.